RESUMO
Ethylene glycol (EG) exposure is a common model for kidney stones, because animals accumulate calcium oxalate monohydrate (COM) in kidneys. Wistar rats are more sensitive to EG than Fischer 344 (F344) rats, with greater COM deposition in kidneys. The mechanisms by which COM accumulates differently among strains are poorly understood. Urinary proteins inhibit COM adhesion to renal cells, which could alter COM deposition in kidneys. We hypothesize that COM accumulates more in Wistar rat kidneys because of lower levels of inhibitory proteins in urine. Wistar and F344 rats were treated with 0.75% EG in drinking water for 8 wk. Twenty-four-hour urine was collected every 2 wk for analysis of urinary proteins. Similar studies were conducted for 2 wk using 2% hydroxyproline (HP) as an alternative oxalate source. Total urinary protein was higher in F344 than Wistar rats at all times. Tamm-Horsfall protein was not different between strains. Osteopontin (OPN) levels in Wistar urine and kidney tissue were higher and were further increased by EG treatment. This increase in OPN occurred before renal COM accumulation. Untreated F344 rats showed greater CD45 and ED-1 staining in kidneys than untreated Wistars; in contrast, EG treatment increased CD45 and ED-1 staining in Wistars more than in F344 rats, indicating macrophage infiltration. This increase occurred in parallel with the increase in OPN and before COM accumulation. Like EG, HP induced markedly greater oxalate concentrations in the plasma and urine of Wistar rats compared with F344 rats. These results suggest that OPN upregulation and macrophage infiltration do not completely protect against COM accumulation and may be a response to crystal retention. Because the two oxalate precursors, EG and HP, produced similar elevations of oxalate, the strain difference in COM accumulation may result more so from metabolic differences between strains than from differences in urinary proteins or inflammatory responses.
Assuntos
Etilenoglicol/efeitos adversos , Cálculos Renais/induzido quimicamente , Cálculos Renais/epidemiologia , Mucoproteínas/urina , Osteopontina/urina , Animais , Oxalato de Cálcio/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Etilenoglicol/farmacologia , Hidroxiprolina/efeitos adversos , Hidroxiprolina/farmacologia , Rim/metabolismo , Masculino , Ratos , Ratos Endogâmicos F344 , Ratos Wistar , Fatores de Risco , Especificidade da Espécie , UromodulinaRESUMO
IgA nephropathy (IgAN) is one of the most common types of glomerulonephritis worldwide and is diagnosed only with a renal biopsy. The purpose of the present studies was to identify the potential biomarkers for the non-invasive diagnosis of IgAN. The combination of a magnetic bead separation system with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) was used to analyze urinary peptides of IgAN patients, other glomerulopathy patients, and healthy controls. ClinProTools v.2.0 software was also applied to establish a diagnostic model for IgAN. Our results demonstrated that 11 features had optimal discriminatory performance (p <0.00001). Among these features, the peptide with m/z 1913.14 was identified as a fragment of uromodulin. Receiver operating characteristic (ROC) analysis for m/z 1913.14 showed that the area under the curve (AUC) was 0.998 for distinguishing IgAN versus healthy controls, and 0.815 for distinguishing IgAN versus other glomerulopathy. Analysis of urine peptides patterns by the magnetic bead separation system and MALDI-TOF-MS was a non-invasive diagnostic tool. We conclude that the urinary peptide with m/z 1913.14, which was identified as a uromodulin fragment, may be used as a biomarker for the non-invasive diagnosis of IgAN clinically.
Assuntos
Glomerulonefrite por IGA/diagnóstico , Mucoproteínas/química , Adulto , Biomarcadores/química , Biomarcadores/urina , Estudos de Casos e Controles , Feminino , Glomerulonefrite por IGA/urina , Humanos , Masculino , Mucoproteínas/urina , Uromodulina , Adulto JovemRESUMO
BACKGROUND: Uromodulin (also known as Tamm-Horsfall protein) is the most abundant urinary protein in healthy individuals and exhibits diverse functions including prevention of ascending urinary tract infections by binding type I-fimbriated Escherichia coli. Although uromodulin is targeted to the apical membrane of thick ascending limb (TAL) cells and secreted into the lumen, detectable levels are also found in venous blood. Uromodulin has been shown to interact with and activate specific components of the immune system, and thus, may act as a signalling molecule for renal tubular damage. METHODS: In order to investigate the potential involvement of uromodulin in chronic kidney disease (CKD), we quantified uromodulin in paired urine and serum from 14 healthy volunteers and 77 CKD patients. Clinical parameters such as estimated GFR (eGFR), proteinuria and urinary N-acetyl-beta-D-glucosaminidase (NAG) were measured. Mean infiltration and atrophy score were assessed in patient biopsies. Additionally, tumour necrosis factor-alpha, interleukin-6 (IL-6), IL-8 and IL-1 beta were measured in serum samples. RESULTS: eGFR correlated positively with urinary uromodulin and negatively with serum uromodulin. Patients with abnormally low urinary uromodulin showed a broader range of serum uromodulin. Patients with both very low urinary and serum uromodulin had the highest tubular atrophy scores. There was a positive correlation of serum uromodulin with all cytokines measured. Additionally, in in vitro experiments, uromodulin caused a dose-dependent increase in pro-inflammatory cytokine release from whole blood. CONCLUSIONS: Our data suggest that TAL damage, or damage distal to the TAL, results in an elevated interstitial uromodulin, which stimulates an inflammatory response. Persistent chronic TAL damage reduces TAL cell numbers and attenuates urinary and serum uromodulin concentrations. The combined analysis of serum and urinary uromodulin provides new insights into the role of uromodulin in CKD and suggest that uromodulin may be an active player in CKD progression.
Assuntos
Falência Renal Crônica/fisiopatologia , Mucoproteínas/fisiologia , Insuficiência Renal Crônica/fisiopatologia , Estudos de Casos e Controles , Estudos de Coortes , Creatinina/sangue , Citocinas/sangue , Progressão da Doença , Taxa de Filtração Glomerular , Humanos , Hiperuricemia/genética , Hiperuricemia/fisiopatologia , Mediadores da Inflamação/sangue , Falência Renal Crônica/etiologia , Túbulos Renais/patologia , Túbulos Renais/fisiopatologia , Mucoproteínas/sangue , Mucoproteínas/genética , Mucoproteínas/urina , Mutação , Insuficiência Renal Crônica/etiologia , UromodulinaRESUMO
Common variants in the region of the UMOD gene, which encodes uromodulin (Tamm-Horsfall protein), associate with chronic kidney disease (CKD) and estimated GFR (eGFR). Whether uromodulin levels associate with UMOD variants or with the risk for developing CKD is unknown. We conducted an age- and gender-matched case-control study (n = 200) of incident CKD (eGFR <60 ml/min per 1.73 m(2)) within the Framingham Heart Study (FHS). Baseline urinary uromodulin concentrations were related to case-control status 9.9 yr later and to genotype at rs4293393. As a replication set, we tested the genotype association with uromodulin concentration in the Atherosclerosis Risk in Communities (ARIC) Study (n = 42). Geometric means of uromodulin concentrations were 51% higher in case than in control subjects (P = 0.016). The adjusted odds ratio of CKD per 1-SD higher concentration of uromodulin was 1.72 (95% confidence interval 1.07 to 2.77; P = 0.03) after accounting for CKD risk factors and baseline eGFR. We observed lower urinary uromodulin concentrations per each copy of the C allele at rs4293393 in both cohorts. In summary, elevated uromodulin concentrations precede the onset of CKD and associate with a common polymorphism in the UMOD region.
Assuntos
Predisposição Genética para Doença/genética , Nefropatias/genética , Nefropatias/urina , Mucoproteínas/genética , Mucoproteínas/urina , Polimorfismo de Nucleotídeo Único/genética , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Doença Crônica , Feminino , Genótipo , Taxa de Filtração Glomerular/fisiologia , Humanos , Nefropatias/fisiopatologia , Doenças Renais Císticas/genética , Masculino , Pessoa de Meia-Idade , Proteínas Motores Moleculares/genética , Cadeias Pesadas de Miosina/genética , Fatores de Risco , UromodulinaRESUMO
The growth of calcium oxalate monohydrate in the presence of Tamm-Horsfall protein (THP), osteopontin, and the 27-residue synthetic peptides (DDDS)(6)DDD and (DDDG)(6)DDD (D = aspartic acid, S = serine, and G = glycine) was investigated via in situ atomic force microscopy. The results show that these four growth modulators create extensive deposits on the crystal faces. Depending on the modulator and crystal face, these deposits can occur as discrete aggregates, filamentary structures, or uniform coatings. These proteinaceous films can lead to either the inhibition of or an increase in the step speeds (with respect to the impurity-free system), depending on a range of factors that include peptide or protein concentration, supersaturation, and ionic strength. While THP and the linear peptides act, respectively, to exclusively increase and inhibit growth on the (101) face, both exhibit dual functionality on the (010) face, inhibiting growth at low supersaturation or high modulator concentration and accelerating growth at high supersaturation or low modulator concentration. Based on analyses of growth morphologies and dependencies of step speeds on supersaturation and protein or peptide concentration, we propose a picture of growth modulation that accounts for the observations in terms of the strength of binding to the surfaces and steps and the interplay of electrostatic and solvent-induced forces at the crystal surface.
Assuntos
Oxalato de Cálcio/química , Mucoproteínas/química , Osteopontina/química , Peptídeos/química , Ácido Aspártico/química , Cristalização , Glicina/química , Humanos , Cinética , Microscopia de Força Atômica , Mucoproteínas/urina , Osteopontina/urina , Serina/química , Cálculos Urinários/química , UromodulinaRESUMO
Painful bladder syndrome/interstitial cystitis (PBS/IC) is a controversial subject. Despite its many controversies, recent data on diagnostics show that cystoscopy and hydrodistension findings may not be sensitive or specific. Diagnosis is suggested primarily on the basis of history. Antiproliferative factor and Tamm-Horsfall protein are novel tests that may prove to be worthwhile pending future studies. Currently, there is no single diagnostic gold standard. Recent data on therapeutics show that, among oral therapies, amitriptyline and pentosan are efficacious. For best response, pentosan should be initiated early and used for a minimum of 6 months. Immune-modulating agents show promise but are limited by side effects. Intravesical alkalinized lidocaine with heparin may be effective for rapid symptom relief, pending results of prospective randomized trials. Intravesical botulinum toxin A, bacille Calmette-Guérin, and sacral neuromodulation may have a role in select patients.
Assuntos
Cistite Intersticial/diagnóstico , Cistite Intersticial/tratamento farmacológico , Urologia/tendências , Amitriptilina/efeitos adversos , Amitriptilina/uso terapêutico , Analgésicos não Narcóticos/efeitos adversos , Analgésicos não Narcóticos/uso terapêutico , Cistite Intersticial/dietoterapia , Cistite Intersticial/urina , Cistoscopia/normas , Glicoproteínas/urina , Humanos , Fatores Imunológicos/efeitos adversos , Fatores Imunológicos/uso terapêutico , Peptídeos e Proteínas de Sinalização Intercelular , Mucoproteínas/urina , Poliéster Sulfúrico de Pentosana/efeitos adversos , Poliéster Sulfúrico de Pentosana/uso terapêutico , Sensibilidade e Especificidade , UromodulinaRESUMO
Kidney stone disease affects 1 - 20% of the general population. At present, the diagnosis of a stone is done using radiography method when noticeable symptoms appeared. We developed a non-invasive quantitative assay for urinary THP, namely ELISA; whereby our previous study and other reports had shown the usefulness of THP as biomarker for kidney stone disease. Since urine is biological fluid that is easily obtainable, this method could be used as a screening assay for kidney stone prior to confirmation with radiography. The ELISA gave assay linearity r(2) > 0.999 within the range of 109 ng/mL to 945 ng/mL THP. Assay precisions were < 4% (C.V.) for repeatability and < 5% (C.V.) for reproducibility. Assay accuracy range from 97.7% to 101.2% at the various THP concentrations tested. Assay specificity and sensitivity were 80% and 86%, respectively. The cut-off points at P < 0.05 were 37.0 and 41.2 mug/mL for male and female, respectively. The assay is cost effective and rapid whereby the cost for assaying each urine sample in duplicate is approximately USD0.35 and within 5 hours, 37 samples can be assayed alongside full range of standards and 3 QC samples in each plate. Furthermore, sample preparation is relatively easy where urine sample was diluted 10 times in TEA buffer. The usability of the ELISA method for diagnosis of kidney stone disease is evaluated with 117 healthy subjects and 58 stone formers.
Assuntos
Cálculos Renais/diagnóstico , Cálculos Renais/urina , Mucoproteínas/urina , Adulto , Idoso , Idoso de 80 Anos ou mais , Ensaio de Imunoadsorção Enzimática/métodos , Feminino , Humanos , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Uromodulina , Adulto JovemRESUMO
Uromodulin (UMOD) malfunction has been found in a range of autosomal dominant tubulointerstitial nephropathies associated with hyperuricaemia, gouty arthritis, medullary cysts and renal failure-labelled as familial juvenile hyperuricaemic nephropathy, medullary cystic disease type 2 and glomerulocystic kidney disease. To gain knowledge of the spectrum of UMOD changes in various genetic diseases with renal involvement we examined urinary UMOD excretion and found significant quantitative and qualitative changes in 15 male patients at various clinical stages of Fabry disease. In untreated patients, the changes ranged from normal to a marked decrease, or even absence of urinary UMOD. This was accompanied frequently by the presence of aberrantly processed UMOD lacking the C-terminal part following the K432 residue. The abnormal patterns normalized in all patients on enzyme replacement therapy and in some patients on substrate reduction therapy. Immunohistochemical analysis of the affected kidney revealed abnormal UMOD localization in the thick ascending limb of Henle's loop and the distal convoluted tubule, with UMOD expression inversely proportional to the degree of storage. Our observations warrant evaluation of tubular functions in Fabry disease and suggest UMOD as a potential biochemical marker of therapeutic response of the kidney to therapy. Extended comparative studies of UMOD expression in kidney specimens obtained during individual types of therapies are therefore of great interest.
Assuntos
Doença de Fabry/tratamento farmacológico , Doença de Fabry/metabolismo , Túbulos Renais/metabolismo , Mucoproteínas/metabolismo , Processamento de Proteína Pós-Traducional , alfa-Galactosidase/uso terapêutico , Adulto , Sequência de Aminoácidos , Biomarcadores/metabolismo , Doença de Fabry/patologia , Feminino , Humanos , Nefropatias/etiologia , Nefropatias/metabolismo , Nefropatias/patologia , Túbulos Renais/patologia , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Mucina-1/metabolismo , Mucoproteínas/urina , Triexosilceramidas/metabolismo , UromodulinaRESUMO
OBJECTIVE: The purpose of this study was to identify differences in urine proteins between patients with interstitial cystitis (IC) and asymptomatic control (AC) subjects with the use of proteomic techniques. STUDY DESIGN: Nine patients with IC and their age-, race-, and sex-matched AC subjects volunteered a urine specimen. Urine proteins were separated with the use of 2-dimensional polyacrylamide gels. Differing proteins underwent digestion and matrix-assisted laser desorption ionization-time of flight mass spectrometry. Computer-assisted data analysis was used to identify the corresponding protein. Differences in urine protein responses between patients with IC and AC subjects were evaluated by the Mann-Whitney U test to account for the nonnormal frequency distribution of the parameter estimate or chi-square when data were bimodal. RESULTS: Four proteins differed significantly between patients with IC and AC subjects. The AC subjects had a greater concentration of a uromodulin (P = .019) and two kininogens (P = .023, .046). The patients with IC had a greater concentration of inter-alpha-trypsin inhibitor heavy chain H4 (P = .019). CONCLUSION: These urine protein isoforms may be biomarkers for IC.
Assuntos
Cistite Intersticial/diagnóstico , Proteínas/análise , Proteômica , Urina/química , Adolescente , Adulto , Idoso , alfa-Globulinas/urina , Biomarcadores/urina , Proteínas Sanguíneas/urina , Cistite Intersticial/urina , Diagnóstico Diferencial , Eletroforese em Gel de Poliacrilamida , Feminino , Glicoproteínas/urina , Humanos , Cininogênios/urina , Masculino , Pessoa de Meia-Idade , Mucoproteínas/urina , Isoformas de Proteínas , Proteínas Secretadas Inibidoras de Proteinases/urina , Qualidade de Vida , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , UromodulinaRESUMO
In a previous study, we found urinary excretion of Tamm-Horsfall protein (THP) to be persistently decreased in 25% of patients during the first year after diagnosis of diabetes mellitus. We thus wanted to study another marker for distal tubular function, pi glutathione S-transferase (pi-GST) and compare this and THP with proximal tubular function evaluated with alpha-GST and alpha-1-microglobulin (HC) in patients with longer duration of diabetes. One hundred and eighty-four diabetic and 16 control children were studied with timed overnight urine collections. Median age was 14 years, and median age at diagnosis was 8 years. The urinary excretion of alpha- and pi-GST was significant lower in diabetic than control children. There were no differences in the excretion of HC and THP. Diabetic children with decreased alpha-GST had higher albumin excretion, HbA 1c levels, and longer diabetes duration but decreased THP excretion and cystatin-C clearance compared with those with normal excretion. In contrast, a decreased pi-GST or THP excretion was not associated with such differences. Diabetic children with increased HC excretion had increased HbA 1c levels. Diabetic children, before the stage of microalbuminuria, may have signs of both proximal and distal tubular dysfunction, which is related to diabetes duration and poor metabolic control. Alpha-GST and pi-GST seem to be more sensitive than other parameters studied.
Assuntos
Diabetes Mellitus Tipo 1/urina , Nefropatias Diabéticas/diagnóstico , Glutationa S-Transferase pi/urina , Glutationa Transferase/urina , Isoenzimas/urina , Testes de Função Renal , Túbulos Renais/enzimologia , Mucoproteínas/urina , Adolescente , Adulto , alfa-Globulinas/urina , Biomarcadores/urina , Estudos de Casos e Controles , Criança , Pré-Escolar , Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/fisiopatologia , Nefropatias Diabéticas/etiologia , Nefropatias Diabéticas/fisiopatologia , Nefropatias Diabéticas/urina , Diagnóstico Precoce , Feminino , Hemoglobinas Glicadas/urina , Humanos , Túbulos Renais/fisiopatologia , Masculino , Valor Preditivo dos Testes , UromodulinaRESUMO
PURPOSE: Normal urinary Tamm-Horsfall protein shows a urothelial cytoprotective effect against potentially toxic compounds in urine that may injure the urothelium and cause bladder disease. One such disease is interstitial cystitis. In patients with interstitial cystitis this protective effect is decreased. We hypothesized that a difference in Tamm-Horsfall protein in patients with interstitial cystitis exists that may be involved in disease pathogenesis. MATERIALS AND METHODS: Using enzyme-linked immunosorbent assay the urinary Tamm-Horsfall protein concentration was determined in patients with interstitial cystitis and control subjects. Sialic acid content was measured by high performance liquid chromatography based assay. The structure of the protein glycosylation chains was analyzed using matrix assisted laser desorption/ionization-time of flight mass spectrometry. RESULTS: The mean Tamm-Horsfall protein concentration was not significantly different in patients with interstitial cystitis and controls (28.8 vs 28.2 mg/l urine and 36.8 vs 36.7 microg/mg creatinine, respectively, p = 0.6). The total mean sialic acid content of Tamm-Horsfall protein was almost 2-fold lower in 22 patients with interstitial cystitis compared with that in 20 controls (46.3 +/- 4.3 vs 75.3 +/- 4.1 nmol sialic acid per mg Tamm-Horsfall protein, respectively, p <0.0001). On matrix assisted laser desorption/ionization-time of flight mass spectrometry N-glycans released from Tamm-Horsfall protein revealed lower molecular weight di-antennary N-glycan structures and a resulting decrease in the number of terminal sialic acid residues in 10 patients with interstitial cystitis relative to those in 10 controls. CONCLUSIONS: Tamm-Horsfall protein is qualitatively different in patients with interstitial cystitis compared to controls. These data suggest that altered Tamm-Horsfall protein may be involved in interstitial cystitis pathogenesis and it may be useful for clinical diagnosis.
Assuntos
Cistite Intersticial/diagnóstico , Cistite Intersticial/urina , Mucoproteínas/metabolismo , Adulto , Biomarcadores/urina , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Cistoscopia/métodos , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Mucoproteínas/urina , Mucosa/fisiopatologia , Prognóstico , Valores de Referência , Fatores de Risco , Índice de Gravidade de Doença , Urinálise , UromodulinaRESUMO
OBJECTIVES: Tamm-Horsfall protein (THP) from normal urine has been shown to protect against the cytotoxic effects of toxic urinary cations (TFs) in vivo and in vitro. This study investigated the effect of desialylation on the cytoprotective activity of THP. METHODS: From pooled 24-hour urine specimens from healthy individuals, both TFs and THP were obtained. Sprague-Dawley rats received intravesical NaCl or KCl, and the baseline urodynamic percentage of nonvoiding contractions (NVCs) was recorded. Then, rehydrated TF, TF plus THP, or TF plus THP-desialylated (THP-d) were instilled, followed by KCl, and the urodynamic measurements were repeated. In vitro, human HTB4 bladder cells were incubated overnight with the rehydrated TF, TF plus THP, TF plus THP-d, or assay media alone, and the cytotoxicity levels were determined. RESULTS: Acid hydrolysis resulted in an 88% loss of sialic acid. TFs consistently demonstrated a greater than 50% toxicity for human HTB4 cells compared with cells incubated in media (P <0.01). TF cytotoxic activity was blocked by preincubation with THP but not by preincubation with THP-d. Similarly, rat bladder NVCs increased significantly over baseline when KCl was infused after TF infusion (1.68 NVCs/min; P <0.0001). NVCs were significantly reduced by preincubating TFs with THP (0.42 NVCs/min) but not by preincubating with THP-d (1.55 NVCs/min, P <0.0001). CONCLUSIONS: The cytoprotective function of urinary THP in the bladder can be compromised when a decrease is present in the sialic acid residues on THP. Such a decrease in THP cytoprotective activity may play a critical role in the pathophysiology of interstitial cystitis.
Assuntos
Antígenos de Grupos Sanguíneos/fisiologia , Citoproteção/fisiologia , Mucoproteínas/fisiologia , Ácido N-Acetilneuramínico/fisiologia , Bexiga Urinária/fisiologia , Adulto , Animais , Assialoglicoproteínas , Antígenos de Grupos Sanguíneos/urina , Células Cultivadas , Cistite Intersticial/fisiopatologia , Testes Imunológicos de Citotoxicidade , Feminino , Humanos , Masculino , Mucoproteínas/urina , Ratos , Ratos Sprague-Dawley , Urodinâmica , UromodulinaRESUMO
In bone and teeth formation, coordinated calcification is a highly desirable biological process. However, heterotopic calcification at unwanted tissue sites leads to dysfunction, disease and, potentially, to death and therefore requires prevention and treatment. With the recent discovery of calcification inhibitors we now know that biological calcification is not passive but a complex, active and highly regulated process. Calcification at vascular sites is the most threatening localization and manifests as part of atherosclerosis or arteriosclerosis. Atherosclerosis is often accompanied by intimal plaque calcification, whereas arteriosclerosis is characterized by calcification of the media. The severity of calcification of cerebral or coronary atherosclerotic plaques is associated with an increased incidence of events such as stroke or myocardial infarction. Medial calcification is the major cause of arterial stiffness, which contributes to left ventricular dysfunction and heart failure. Patients with chronic kidney disease are at especially increased risk for both intimal and medial calcification. In this context, it is currently thought that calcium-regulatory factors including fetuin-A, matrix Gla protein, osteoprotegerin, and pyrophosphates act in a local or systemic manner to prevent calcifications of the vasculature, and that dys-regulations of such calcification inhibitors may contribute to progressive calcifications. Nephrolithiasis represents another process of unwanted calcification responsible for significant morbidity. More than 80% of renal stones contain calcium. Urinary factors inhibiting calcification are citrate, glycosaminoglycans, Tamm-Horsfall protein, and osteopontin. This review summarizes current experimental and clinical data underlining the biological importance of these calcification inhibitors.
Assuntos
Calcinose/sangue , Calcinose/urina , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/urina , Animais , Biomarcadores/sangue , Biomarcadores/urina , Proteínas Sanguíneas/metabolismo , Proteínas de Ligação ao Cálcio/sangue , Ácido Cítrico/urina , Difosfatos/sangue , Proteínas da Matriz Extracelular/sangue , Glicosaminoglicanos/urina , Humanos , Mucoproteínas/urina , Osteopontina/urina , Osteoprotegerina/sangue , Uremia/sangue , Uremia/urina , Uromodulina , alfa-2-Glicoproteína-HS , Proteína de Matriz GlaRESUMO
Our aim was to determine whether fractionation of human urine affects the attachment of calcium oxalate monohydrate (COM) crystals to renal cells. Urine collected from six healthy subjects was fractionated into sieved (S), centrifuged (C), centrifuged and filtered (CF), or ultrafiltered (UF). Attachment of [(14)C]COM crystals to Madin-Darby canine kidney (MDCK) cells was studied after precoating the crystals or the cells with the urine fractions and by using the same fractions as the binding medium. Protein content of the fractions and precoated crystals was analyzed with SDS-PAGE and Western blotting. All urine fractions inhibited crystal attachment. When fractions from the six urine samples were used to precoat the cells, the median inhibitions of crystal adhesion ( approximately 40%) were not significantly different. Median inhibition after preincubation of crystals was the same for the S, C, and CF fractions ( approximately 40%) but significantly greater than for the UF fraction ( approximately 28%). When fractions were used as the binding medium, median inhibitions decreased from 64% in the S fraction to 47 (C), 42 (CF), and to 29% (UF). SDS-PAGE analysis showed that centrifugation and filtration reduced the amount of Tamm-Horsfall glycoprotein (THG), which was confirmed by Western blotting. Human serum albumin, urinary prothrombin fragment 1, and osteopontin, but not THG, were present in demineralized extracts of the precoated crystals. Fractionation of human urine affects the attachment of COM crystals to MDCK cells. Hence future studies investigating regulation of crystal-cell interactions should be carried out in untreated urine as the binding medium.
Assuntos
Oxalato de Cálcio/antagonistas & inibidores , Oxalato de Cálcio/química , Fracionamento Químico , Células Epiteliais/metabolismo , Cálculos Renais/etiologia , Rim/metabolismo , Urina/química , Urina/fisiologia , Adesividade , Albuminúria , Animais , Linhagem Celular , Cristalização , Cães , Humanos , Rim/citologia , Mucoproteínas/urina , Osteopontina/urina , Fragmentos de Peptídeos/urina , Precursores de Proteínas/urina , Protrombina/urina , UromodulinaRESUMO
Autosomal dominant medullary cystic kidney disease type 2 (MCKD2) is a tubulo-in terstitial nephropathy that causes renal salt wasting, hyperuricemia, gout, and end-stage renal failure in the fifth decade of life. This disorder was described to have an age of onset between the age of 20-30 years or even later. Mutations in the Uromodulin (UMOD) gene were published in patients with familial juvenile hyperuricemic nephropathy (FJHN) and MCKD2. Clinical data and blood samples of 16 affected individuals from 11 different kindreds were collected. Mutational analysis of the UMOD gene was performed by exon polymerase chain reaction (PCR) and direct sequencing. We found the heterozygous C744G (Cys248Trp) mutation, which was originally published by our group, in an additional four kindreds from Europe and Turkey. Age of onset ranged from 3 years to 39 years. The phenotype showed a variety of symptoms such as urinary concentration defect, vesicoureteral reflux, urinary tract infections, hyperuricemia, hypertension, proteinuria, and renal hypoplasia. Haplotype analysis showed cosegragation with the phenotype in all eight affected individuals indicating that the C744G mutation may be due to a founder effect. Moreover, we describe a novel T229G (Cys77Gly) mutation in two affecteds of one kindred. Three of the affected individuals were younger than 10 years at the onset of MCKD2/FJHN. Symptoms include recurrent urinary tract infections compatible with the published phenotype of the Umod knockout mouse model. This emphasizes that MCKD2 is not just a disease of the young adult but is also relevant for children.
Assuntos
Hiperuricemia/genética , Nefropatias/genética , Mucoproteínas/genética , Mutação Puntual/genética , Rim Policístico Autossômico Dominante/genética , Adolescente , Adulto , Idade de Início , Criança , Pré-Escolar , Cistina , Análise Mutacional de DNA , Europa (Continente) , Éxons/genética , Feminino , Glicina , Haplótipos/genética , Humanos , Hiperuricemia/urina , Nefropatias/urina , Masculino , Pessoa de Meia-Idade , Mucoproteínas/urina , Linhagem , Fenótipo , Rim Policístico Autossômico Dominante/urina , Turquia , UromodulinaRESUMO
Autosomal dominant hyperuricemia, gout, renal cysts, and progressive renal insufficiency are hallmarks of a disease complex comprising familial juvenile hyperuricemic nephropathy and medullary cystic kidney diseases type 1 and type 2. In some families the disease is associated with mutations of the gene coding for uromodulin, but the link between the genetic heterogeneity and mechanism(s) leading to the common phenotype symptoms is not clear. In 19 families, we investigated relevant biochemical parameters, performed linkage analysis to known disease loci, sequenced uromodulin gene, expressed and characterized mutant uromodulin proteins, and performed immunohistochemical and electronoptical investigation in kidney tissues. We proved genetic heterogeneity of the disease. Uromodulin mutations were identified in six families. Expressed, mutant proteins showed distinct glycosylation patterns, impaired intracellular trafficking, and decreased ability to be exposed on the plasma membrane, which corresponded with the observations in the patient's kidney tissue. We found a reduction in urinary uromodulin excretion as a common feature shared by almost all of the families. This was associated with case-specific differences in the uromodulin immunohistochemical staining patterns in kidney. Our results suggest that various genetic defects interfere with uromodulin biology, which could lead to the development of the common disease phenotype. 'Uromodulin-associated kidney diseases' may be thus a more appropriate term for this syndrome.
Assuntos
Heterogeneidade Genética , Hiperuricemia/genética , Rim/patologia , Mucoproteínas/genética , Rim Policístico Autossômico Dominante/genética , Adolescente , Adulto , Sequência de Bases , Membrana Basal/patologia , Membrana Basal/ultraestrutura , Biópsia , Células Cultivadas , Criança , Cromossomos Humanos Par 1 , Cromossomos Humanos Par 16 , Análise Mutacional de DNA , Feminino , Ligação Genética , Gota , Humanos , Hiperuricemia/metabolismo , Imuno-Histoquímica , Rim/metabolismo , Rim/cirurgia , Rim/ultraestrutura , Túbulos Renais/patologia , Túbulos Renais/ultraestrutura , Masculino , Mucoproteínas/metabolismo , Mucoproteínas/urina , Mutação de Sentido Incorreto , Linhagem , Hipófise/citologia , Polimorfismo de Fragmento de Restrição , Síndrome , Transfecção , UromodulinaRESUMO
Hyperuricemia and gout are common conditions that have long been known to have a heritable component. Obesity, diabetes, and chronic kidney failure are conditions with multifactorial inheritance that are associated with gout. In addition, social factors such as protein and alcohol intake affect serum uric acid levels. The current review discusses basic uric acid metabolism and the multigenetic inheritance of hyperuricemia. Several monogenic disorders affecting uric acid metabolism are reviewed. The genetics, pathophysiology, diagnosis, and treatment of familial juvenile hyperuricemic nephropathy/medullary cystic kidney disease, autosomal dominant disorders associated with hyperuricemia and progressive kidney failure, are described.
Assuntos
Predisposição Genética para Doença , Gota/genética , Hiperuricemia/genética , Antígenos de Grupos Sanguíneos , Marcadores Genéticos , Gota/complicações , Gota/metabolismo , Humanos , Hiperuricemia/complicações , Hiperuricemia/metabolismo , Mucoproteínas/urina , Mutação , Insuficiência Renal/etiologia , Insuficiência Renal/genética , Insuficiência Renal/metabolismo , Fatores de Risco , Urato Oxidase/genética , Urato Oxidase/metabolismo , Ácido Úrico/sangue , UromodulinaRESUMO
BACKGROUND: Oral supplementation of l-arginine (l-arg) is found to be beneficial in many kidney disorders. We determined whether l-arg supplementation safeguards the renal epithelial cell damage induced by hyperoxaluria with excretion of urinary marker enzymes and lithogenic salts with special reference to Tamm-Horsfall glycoprotein (THP). METHODS: Hyperoxaluria was induced by 0.75% ethylene glycol (EG) in drinking water. l-Arg was co-supplemented at the dose of 1.25 g/kg b.w. orally for 28 days. At the end of experimental period, 24-h urine samples were collected in all the experimental groups. Isolation and purification of THP was carried in rat urine and were subjected to spectrophotometric crystallization assay and calcium-(14)C-oxalate binding studies. Determination of the lithogenic risk factors like calcium, oxalate, phosphorus, citrate, and marker enzymes such as lactate dehydrogenase (LDH) and gamma-glutamyltransferase (gamma-GT) were carried out in the collected urine sample. RESULTS: Urinary excretion of calcium and oxalate was significantly increased in EG-treated rats. In l-arg supplemented hyperoxaluric rats, these concentrations were significantly (p<0.001) decreased when compared to that of hyperoxaluric rats, and were moderately elevated from that of control rats. The activities of urinary marker enzymes, both LDH and gamma-GT were 2-fold increased in EG-treated rats, when compared to control rats, but these values were maintained near normal in l-arg supplemented EG-treated rats. Citrate excretion was enhanced in the l-arg co-supplemented hyperoxaluric rats. In spectrophotometric crystallization assay system, l-arg supplemented rat THP showed inhibition in nucleation and aggregation phases, whereas EG-treated rat THP showed promotion of both calcium oxalate nucleation and aggregation phases. In calcium-(14)C-oxalate binding assay, THP derived from hyperoxaluric rats exhibited 2-fold increase (p<0.001) in the Ca*Ox binding when compared to control and l-arg supplemented animals. CONCLUSIONS: l-Arg could act as a potent antilithic agent, by increasing the level of citrate in the hyperoxaluria-induced rats and decreasing calcium oxalate binding to the THP. l-Arg also effectively prevents the deposition of calcium oxalate crystals by curtailing the renal epithelial damage and protein oxidation as evidenced by the normal activities of urinary marker enzymes in l-arg supplemented hyperoxaluric rats.
Assuntos
Arginina/administração & dosagem , Hiperoxalúria/tratamento farmacológico , Hiperoxalúria/urina , Mucoproteínas/urina , Animais , Biomarcadores/urina , Compostos de Cálcio/análise , Oxalato de Cálcio/metabolismo , Ácido Cítrico/urina , Ensaios Enzimáticos Clínicos , Suplementos Nutricionais , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/patologia , Etilenoglicol , Hiperoxalúria/induzido quimicamente , Rim/patologia , Masculino , Mucoproteínas/isolamento & purificação , Mucoproteínas/metabolismo , Óxidos/análise , Substâncias Protetoras/administração & dosagem , Ratos , Ratos Wistar , Fatores de Risco , UromodulinaRESUMO
OBJECTIVES: Most clinical laboratories replaced their manual precipitation techniques for the determination of urinary protein with automated dye binding assays or benzethonium chloride-turbidimetric assays. Few studies have validated these assays for the measurement of urinary proteins in the normal range. DESIGN AND METHODS: This study compares four automated assays for the measurement of urinary protein to a manual Ponceau S/TCA precipitation assay. We evaluated the linearity, the precision, the analytical sensitivity, the accuracy and the recovery of different proteins for each assay. RESULTS: All assays showed good linearity with the theoretical concentration of albumin present in the sample. The coefficient of variation was below 10% at a concentration of 0.142 g/L. However, the manual Ponceau S/TCA assay demonstrated superior analytical sensitivity. Accuracy determinations showed a variable positive bias and poor correlations at concentrations below 0.1 g/L when compared to the Ponceau S/TCA assay. Small molecular weight peptides particularly affected the pyrogallol red assays but other urinary components also interfered with the automated assays. CONCLUSIONS: Most automated assays show high imprecision and poor accuracy for the measurement of urinary protein in the normal range. The Ponceau S/TCA offers a precise and accurate manual alternative to these automated assays.
Assuntos
Autoanálise , Erros de Diagnóstico , Proteinúria/urina , Albuminúria/urina , Artefatos , Compostos Azo , Calibragem , Corantes , Humanos , Mucoproteínas/urina , Peptídeos/urina , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Albumina Sérica , Uromodulina , gama-Globulinas/urinaRESUMO
The objective of the present study was to evaluate the role of physical exercise as well as the influence of hydration with an isotonic sports drink on renal function in male Wistar rats. Four groups were studied over a period of 42 days: 1) control (N = 9); 2) physical exercise (Exe, N = 7); 3) isotonic drink (Drink, N = 8); 4) physical exercise + isotonic drink (Exe + Drink, N = 8). Physical exercise consisted of running on a motor-driven treadmill for 1 h/day, at 20 m/min, 5 days a week. The isotonic sports drink was a commercial solution used by athletes for rehydration after physical activity, 2 ml administered by gavage twice a day. Urine cultures were performed in all animals. Twenty-four-hour urine samples were collected in metabolic cages at the beginning and at the end of the protocol period. Urinary and plasma parameters (sodium, potassium, urea, creatinine, calcium) did not differ among groups. However, an amorphous material was observed in the bladders of animals in the Exe + Drink and Drink groups. Characterization of the material by Western blot revealed the presence of Tamm-Horsfall protein and angiotensin converting enzyme. Physical exercise and the isotonic drink did not change the plasma or urinary parameters measured. However, the isotonic drink induced the formation of intravesical matrix, suggesting a potential lithogenic risk.